News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
268,184 Results
Type
Article (14252)
Company Profile (281)
Press Release (253651)
Multimedia
Podcasts (48)
Webinars (7)
Section
Business (79538)
Career Advice (152)
Deals (13230)
Drug Delivery (35)
Drug Development (50462)
Employer Resources (32)
FDA (5724)
Job Trends (5133)
News (144443)
Policy (10032)
Tag
Academia (915)
Accelerated approval (2)
Adcomms (12)
Allergies (52)
Alliances (21674)
ALS (64)
Alzheimer's disease (848)
Antibody-drug conjugate (ADC) (100)
Approvals (5752)
Artificial intelligence (124)
Autoimmune disease (18)
Automation (5)
Bankruptcy (105)
Best Places to Work (4559)
BIOSECURE Act (6)
Biosimilars (43)
Biotechnology (232)
Bladder cancer (59)
Brain cancer (20)
Breast cancer (155)
Cancer (1485)
Cardiovascular disease (117)
Career advice (133)
Career pathing (2)
CAR-T (118)
Cell therapy (332)
Cervical cancer (8)
Clinical research (41093)
Collaboration (542)
Compensation (263)
Complete response letters (13)
COVID-19 (1034)
CRISPR (42)
C-suite (165)
Cystic fibrosis (76)
Data (1531)
Denatured (11)
Depression (31)
Diabetes (139)
Diagnostics (1300)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (10)
Drug discovery (85)
Drug pricing (28)
Drug shortages (3)
Duchenne muscular dystrophy (90)
Earnings (29860)
Editorial (18)
Employer branding (4)
Employer resources (30)
Events (48624)
Executive appointments (464)
FDA (6432)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (498)
Gene editing (97)
Generative AI (10)
Gene therapy (254)
GLP-1 (366)
Government (1080)
Grass and pollen (2)
Guidances (27)
Healthcare (6594)
Huntington's disease (22)
IgA nephropathy (25)
Immunology and inflammation (92)
Indications (20)
Infectious disease (1099)
Inflammatory bowel disease (115)
Inflation Reduction Act (8)
Influenza (19)
Intellectual property (67)
Interviews (17)
IPO (7274)
IRA (11)
Job creations (861)
Job search strategy (127)
Kidney cancer (7)
Labor market (5)
Layoffs (209)
Leadership (3)
Legal (1386)
Liver cancer (33)
Lung cancer (205)
Lymphoma (102)
Machine learning (3)
Management (7)
Manufacturing (140)
MASH (54)
Medical device (2600)
Medtech (2601)
Mergers & acquisitions (6287)
Metabolic disorders (391)
Multiple sclerosis (53)
NASH (13)
Neurodegenerative disease (68)
Neuropsychiatric disorders (25)
Neuroscience (1260)
NextGen: Class of 2025 (2017)
Non-profit (852)
Now hiring (21)
Obesity (194)
Opinion (102)
Ovarian cancer (63)
Pain (44)
Pancreatic cancer (56)
Parkinson's disease (121)
Partnered (8)
Patents (130)
Patient recruitment (79)
Peanut (35)
People (25658)
Pharmaceutical (47)
Pharmacy benefit managers (5)
Phase I (14518)
Phase II (19113)
Phase III (12082)
Pipeline (818)
Policy (45)
Postmarket research (852)
Preclinical (6141)
Press Release (30)
Prostate cancer (62)
Psychedelics (35)
Radiopharmaceuticals (213)
Rare diseases (292)
Real estate (1419)
Recruiting (12)
Regulatory (8648)
Reports (15)
Research institute (938)
Resumes & cover letters (17)
Rett syndrome (4)
RNA editing (5)
RSV (10)
Schizophrenia (61)
Series A (98)
Series B (63)
Service/supplier (1)
Sickle cell disease (40)
Special edition (11)
Spinal muscular atrophy (117)
Sponsored (12)
Startups (1975)
State (1)
Stomach cancer (4)
Supply chain (23)
Tariffs (9)
The Weekly (36)
Vaccines (214)
Venture capitalists (32)
Weight loss (110)
Women's health (15)
Worklife (2)
Date
Today (114)
Last 7 days (541)
Last 30 days (1516)
Last 365 days (19540)
2025 (6349)
2024 (20552)
2023 (22417)
2022 (26822)
2021 (27805)
2020 (23360)
2019 (16225)
2018 (11739)
2017 (13745)
2016 (11840)
2015 (14350)
2014 (10392)
2013 (7484)
2012 (7532)
2011 (7614)
2010 (7429)
Location
Africa (148)
Alabama (42)
Alaska (2)
Arizona (53)
Arkansas (5)
Asia (17316)
Australia (2935)
California (3883)
Canada (1143)
China (361)
Colorado (149)
Connecticut (152)
Delaware (103)
Europe (37254)
Florida (468)
Georgia (117)
Idaho (16)
Illinois (233)
India (10)
Indiana (92)
Iowa (2)
Japan (75)
Kansas (62)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (478)
Massachusetts (3094)
Michigan (70)
Minnesota (145)
Mississippi (1)
Missouri (24)
Montana (14)
Nebraska (4)
Nevada (17)
New Hampshire (14)
New Jersey (971)
New Mexico (12)
New York (1050)
North Carolina (556)
North Dakota (5)
Northern California (1714)
Ohio (112)
Oklahoma (9)
Oregon (21)
Pennsylvania (743)
Puerto Rico (6)
Rhode Island (19)
South America (208)
South Carolina (4)
Southern California (1496)
Tennessee (25)
Texas (450)
United States (13327)
Utah (53)
Virginia (79)
Washington D.C. (30)
Washington State (352)
Wisconsin (15)
268,184 Results for "anika therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Anika to Issue First Quarter 2025 Financial Results on Friday, May 9, 2025
April 28, 2025
·
1 min read
Press Releases
Anika Completes Divestiture of Parcus Medical
March 10, 2025
·
4 min read
Press Releases
Anika To Present at the Canaccord Genuity 2025 Musculoskeletal Conference
February 26, 2025
·
1 min read
Press Releases
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 7, 2025
April 8, 2025
·
2 min read
Press Releases
Anika Reports Fourth Quarter and Full Year 2024 Financial Results
March 13, 2025
·
19 min read
Business
Pendopharm renews distribution agreement with Anika Therapeutics Inc. for Cingal, Monovisc, and Orthovisc
Pendopharm is pleased to announce the renewal of its exclusive distribution agreement with Anika Therapeutics Inc (NASDAQ: ANIK) (Anika) for Cingal ® , Monovisc ® and Orthovisc ® through the end of 2030.
May 16, 2024
·
2 min read
Press Releases
Anika to Issue Fourth Quarter and Year-End 2024 Financial Results on Wednesday, March 12, 2025
February 26, 2025
·
1 min read
Business
Anika Reports First Quarter 2024 Financial Results
Anika Therapeutics, Inc., a global joint preservation company in early intervention orthopedics, reported financial results for its first quarter ended March 31, 2024.
May 8, 2024
·
14 min read
Genetown
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 07, 2024
Anika Therapeutics, Inc., a global joint preservation company in early intervention orthopedics, announced that on June 3, 2024, Anika granted: non-statutory stock options covering 96,525 shares of common stock at a per share exercise price of $29.35.
June 7, 2024
·
2 min read
Press Releases
Anika To Participate in December 2024 Investor Conferences
November 25, 2024
·
2 min read
1 of 26,819
Next
